These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Optimising the design of phase II oncology trials: the importance of randomisation. Ratain MJ; Sargent DJ Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773 [TBL] [Abstract][Full Text] [Related]
25. The importance of piloting an RCT intervention. Feeley N; Cossette S; Côté J; Héon M; Stremler R; Martorella G; Purden M Can J Nurs Res; 2009 Jun; 41(2):85-99. PubMed ID: 19650515 [TBL] [Abstract][Full Text] [Related]
26. Open letter in response to the article in the Lancet. Swiss Association of Homoeopathic Physicians Explore (NY); 2006 Jan; 2(1):7. PubMed ID: 16781599 [No Abstract] [Full Text] [Related]
27. Randomised controlled trials (RCTs)--sample size: the magic number (SMJ Vol 44 Issue 4 April 2003). Ang RP Singapore Med J; 2003 Aug; 44(8):432. PubMed ID: 14700427 [No Abstract] [Full Text] [Related]
28. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024 [TBL] [Abstract][Full Text] [Related]
29. Deconstructing evidence in orthodontics: making sense of systematic reviews, randomized clinical trials, and meta-analyses. Rinchuse DJ; Rinchuse DJ; Kandasamy S; Ackerman MB World J Orthod; 2008; 9(2):167-76. PubMed ID: 18575311 [TBL] [Abstract][Full Text] [Related]
30. Study design II. Issues of chance, bias, confounding and contamination. Levin KA Evid Based Dent; 2005; 6(4):102-3. PubMed ID: 16355244 [TBL] [Abstract][Full Text] [Related]
31. Blinded sample size reestimation in non-inferiority trials with binary endpoints. Friede T; Mitchell C; Müller-Velten G Biom J; 2007 Dec; 49(6):903-16. PubMed ID: 17726715 [TBL] [Abstract][Full Text] [Related]
32. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Shrier I; Boivin JF; Steele RJ; Platt RW; Furlan A; Kakuma R; Brophy J; Rossignol M Am J Epidemiol; 2007 Nov; 166(10):1203-9. PubMed ID: 17712019 [TBL] [Abstract][Full Text] [Related]
33. Assessment of risk of bias in randomized clinical trials in surgery. Gurusamy KS; Gluud C; Nikolova D; Davidson BR Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747 [TBL] [Abstract][Full Text] [Related]
34. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. Hutton JL Br J Haematol; 2009 Jun; 146(1):27-30. PubMed ID: 19438480 [TBL] [Abstract][Full Text] [Related]
35. Randomized trials or population-based registries. Bergqvist D; Björck M; Säwe J; Troëng T Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):253-6. PubMed ID: 17689818 [No Abstract] [Full Text] [Related]
36. Randomised controlled trials in orthopaedic surgery and traumatology: overview of parameters and pitfalls. Soucacos PN; Johnson EO; Babis G Injury; 2008 Jun; 39(6):636-42. PubMed ID: 18533154 [TBL] [Abstract][Full Text] [Related]
37. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Glynn RJ; Brookhart MA; Stedman M; Avorn J; Solomon DH Med Care; 2007 Oct; 45(10 Supl 2):S38-43. PubMed ID: 17909381 [TBL] [Abstract][Full Text] [Related]
38. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say? Gravel J; Opatrny L; Shapiro S Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496 [TBL] [Abstract][Full Text] [Related]
39. Randomized phase II trials with a prospective control. Jung SH Stat Med; 2008 Feb; 27(4):568-83. PubMed ID: 17573688 [TBL] [Abstract][Full Text] [Related]
40. Studies should be controlled, randomized, and blinded. Parker RA Clin Pharmacol Ther; 2009 May; 85(5):461-3. PubMed ID: 19381148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]